Effect of maternal anti-HPA-1a antibodies and polyclonal IVIG on the activation status of vascular endothelial cells.
about
Management and outcome of 200 cases of fetomaternal alloimmune thrombocytopenia.Developing recombinant HPA-1a-specific antibodies with abrogated Fcgamma receptor binding for the treatment of fetomaternal alloimmune thrombocytopenia.Neonatal outcome in alloimmune thrombocytopenia after maternal treatment with intravenous immunoglobulin.Antiendothelial αvβ3 Antibodies Are a Major Cause of Intracranial Bleeding in Fetal/Neonatal Alloimmune ThrombocytopeniaNew aspects on the efficacy of high-dose intravenous immunoglobulins in patients with autoimmune thrombocytopenia.Th17 cells reflect colon submucosal pathologic changes in active eosinophilic granulomatosis with polyangiitis
P2860
Effect of maternal anti-HPA-1a antibodies and polyclonal IVIG on the activation status of vascular endothelial cells.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Effect of maternal anti-HPA-1a ...... of vascular endothelial cells.
@ast
Effect of maternal anti-HPA-1a ...... of vascular endothelial cells.
@en
type
label
Effect of maternal anti-HPA-1a ...... of vascular endothelial cells.
@ast
Effect of maternal anti-HPA-1a ...... of vascular endothelial cells.
@en
prefLabel
Effect of maternal anti-HPA-1a ...... of vascular endothelial cells.
@ast
Effect of maternal anti-HPA-1a ...... of vascular endothelial cells.
@en
P2093
P2860
P1476
Effect of maternal anti-HPA-1a ...... of vascular endothelial cells.
@en
P2093
C M Radder
H Beekhuizen
H H H Kanhai
P2860
P304
P356
10.1111/J.1365-2249.2004.02496.X
P577
2004-07-01T00:00:00Z